文献速递治疗药物监测与药物基因组学特殊人群用药

七种新生儿苯巴比妥群体药动学模型预测性能的外部评估

External evaluation of the predictive performance of seven population pharmacokinetic models for phenobarbital in neonates.
PubMed 文献 · Br J Clin Pharmacol · 2021-03-12

本研究利用28名新生儿及小婴儿的治疗药物监测数据,对文献中7个苯巴比妥群体药动学模型进行外部评估。Voller等模型在预测诊断中表现最佳,贝叶斯预测及引入体型与成熟度因素可改善模型预测性能。

要点

  • Voller等模型在预测诊断中表现最佳。
  • 贝叶斯预测使用多于一个观测值可提高预测能力。
  • 引入异速体型缩放和成熟度函数通常可改善预测性能。

核心结论

  • 已发表的苯巴比妥群体药动学模型预测性能存在差异。
  • 贝叶斯预测及引入体型与成熟度因素可提高新生儿模型的可预测性。

研究设计与样本

  • 外部评估研究,使用新生儿和年轻婴儿的治疗药物监测数据,共28名受试者、79个血清浓度。
  • 通过PubMed文献综述识别出7个相关的苯巴比妥群体药动学模型。

主要发现

  • Voller等模型在基于预测的评估中表现最佳。
  • 基于模拟的分析中,Shellhaas等和Marsot等两个模型的标准化预测分布误差服从正态分布。
  • 贝叶斯预测使用多于一个观测值可改善预测能力。
  • 引入异速体型缩放和成熟度函数通常增强预测性能,Vucicevic等模型观察到改善。

临床怎么用

  • 临床可优先考虑Voller等模型进行新生儿苯巴比妥药动学预测。
  • 贝叶斯预测时建议使用多于一个药物浓度观测值以提高准确性。
  • 在模型应用中可考虑引入体型与成熟度因素以改善预测。

局限性

  • 外部数据集样本量较小(28名受试者、79个浓度)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Several studies have reported population pharmacokinetic models for phenobarbital (PB), but the predictive performance of these models has not been well documented. This study aims to do external evaluation of the predictive performance in published pharmacokinetic models. METHODS: Therapeutic drug monitoring data collected in neonates and young infants treated with PB for seizure control was used for external evaluation. A literature review was conducted through PubMed to identify population pharmacokinetic models. Prediction- and simulation-based diagnostics, and Bayesian forecasting were performed for external evaluation. The incorporation of allometric scaling for body size and maturation factors into the published models was also tested for prediction improvement. RESULTS: A total of 79 serum concentrations from 28 subjects were included in the external dataset. Seven population pharmacokinetic studies of PB were identified as relevant in the literature search and included for our evaluation. The model by Voller et al showed the best performance concerning prediction-based evaluation. In simulation-based analyses, the normalized prediction distribution error of two models (those of Shellhaas et al and Marsot et al) obeyed a normal distribution. Bayesian forecasting with more than one observation improved predictive capability. Incorporation of both allometric size scaling and maturation function generally enhanced the predictive performance, with improvement as observed in the model of Vucicevic et al. CONCLUSIONS: The predictive performance of published pharmacokinetic models of PB was diverse. Bayesian forecasting and incorporation of both size and maturation factors could improve the predictability of the models for neonates.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Ryu S, Jung WJ, Jiao Z, et al. External evaluation of the predictive performance of seven population pharmacokinetic models for phenobarbital in neonates. Br J Clin Pharmacol. 2021. PMID: 33638184. doi:10.1111/bcp.14803

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。